Angelo De Rosa

[Oussama Wazni @omwazni]

First combined PFA and Watchman implantation. Note mild proximal ridge edema not interfering with implant zone.
@CleClinicHVTI @tavrkapadia @aymanhusseinmd @nakhla_s

[Angelo De Rosa @AngeloDeRosa4]

Congratulations to the first WATCHMAN FLX PRO implanters!

[BostonSci Cardiology @BSCCardiology]

Congrats to Dr. Mohamed Kanj - @CleClinicHVTI, Dr. Seun Alli - @NovantHealth, Drs. @natale_md & @RPHortonMD - @StDavidsHC, @Drdevignair - @StBernards, and Dr. Saibal Kar - @Los_RoblesCA for completing the 1st ever WATCHMAN FLX™ Pro #LAAC implants in the U.S. this morning!

[Angelo De Rosa @AngeloDeRosa4]

The WATCHMAN FLX Pro Left Atrial Appendage Closure Device has received FDA approval! I’m excited for the future of this therapy as we continue making an impact on the lives of thousands of patients with non-valvular atrial fibrillation.

[BostonSci Cardiology @BSCCardiology]

The WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device has received FDA approval!

Learn how this device is designed to enhance the healing process and optimize #LAAC for more patients: https://t.co/mBTWycZQNt

Safety info: https://t.co/933pl4V44j

[Michelle Obama @MichelleObama]

Here’s to @BillieJeanKing and all the changemakers who broke barriers and opened doors for future generations—and to the @USOpen for raising the bar not just for the tennis world, but for the entire world. 🎾

[Carlos Alcaraz @carlosalcaraz]

A lifelong dream! 🏆💚 You always have to believe! I'm only 20 years old, everything is happening too fast, but I'm very proud of how we work every day. Thank you everyone for your support, from the bottom of my heart! 🙌🏻😍 @Wimbledon

📸 Getty

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

In one week, June 8 at 5pm CET, leading global experts in EP will discuss the clinical evidence, including MANIFEST-PF and EUPORIA behind #PFA during an independent, third-party, CME accredited, educational webinar provided by @radcliffeCARDIO.
Register: https://t.co/CNrTyiDIco

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

Join us for the EU-PORIA Late-Breaking Clinical Trial on May 20th and Watch Prof. @BorisSchmidt5 talk about the real-world use of FARAPULSE PFA only at #HRS2023!
#BSCEMEA #Epeeps #PFA

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

New modality like PFA, new way of thinking in mapping integration. Hear @Mel_Gunawardene' s presentation on a prototype of FARAVIEW™** mapping integration with real case example at the @HRSonline on Saturday, 1:30 Rhythm Theater #2. To learn more on #PFA: https://t.co/yZbyc1r2af

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

Interested in learning more about the evidence behind #PFA?
Join the Radcliffe webinar on June 8 5pm CET, where an esteemed faculty of leading global experts in #EP review the clinical evidence behind #PFA, including MANIFEST-PF and EUPORIA.
Sign up here: https://t.co/wr1N4QZj4f

[Angelo De Rosa @AngeloDeRosa4]

Congratulations! 👏

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

Congratulations to @dr_pmueller and his team from @KKliniken for completing the FARAPULSE evaluation phase with 33 cases in 6 weeks!
We also thank the BSC team, @sattler_ulrike et. al for their support.
Learn more on Farapulse #PFA system here: https://t.co/AcbkxJW4Hm
#BSCEMEA

[Angelo De Rosa @AngeloDeRosa4]

Incredible milestone! A major step forward in our ambition to provide more innovative and personalized approaches for the benefit of doctors and their patients in atrial fibrillation therapy. Congratulations to the #BSCEMEA team involved!

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

We're excited to announce Boston Scientific has obtained CE Mark for POLARx™ FIT cryoballoon catheter, the only cryoablation system offering dual diameter balloon size in one catheter to give an individualised fit for greater procedural flexibility, despite variable anatomies

[IHU Liryc @ihu_liryc]

#Fundraising | Liryc Institute is pleased to announce the renewal of its sponsorship agreement with @bostonsci. The representatives of both institutions have had the opportunity to sign the great patron certificate in front of Liryc’s institutional partners and teams.

[Angelo De Rosa @AngeloDeRosa4]

Honored for #BSCEMEA to receive the E-nnova Health 2022 award. Congratulations to the team involved.

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

BSC won for the second year in a row the E-nnova Health awards in the “IoT en E-Health, Wearables y Robótica” category, recognizing the project of @TE_GranEmpresa / @Tedcas and BSC to implement a solution based on 5G communications for cardiac patient operations.
#BSCEMEA

[World Heart Federation @worldheartfed]

Today on #WorldHeartDay, we are calling for urgent action on climate change and health inequity, with millions more lives now at risk from cardiovascular disease, the world’s biggest killer.

Read our press release: https://t.co/bRrgHNQa0a

USE ❤��� FOR EVERY ❤️ #UseHeart

[Roger Federer @rogerfederer]

❤️

[World Heart Federation @worldheartfed]

Are you ready for the launch of the WHF Roadmap for Digital Health in Cardiology? Join @fjpinto1960, @ProfMartinCowie, @lamcardio, Dr Prabhakaran and @JRedHeart now in Room Gaudi at the #ESCCongress! #CVDRoadmaps

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

HONEST cohort, the largest real world #SICD study of almost 5,000 patients, showed #SICD has a 'favourable benefit-risk ratio' with a low rate of complications and low rate of cross-over to TV-ICD #Extrathoracic #ESCCongress2022

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

@KnopsReinoud presenting #PRAETORIAN sub-analysis showed fewer device-related complications with #SICD, while TV-ICDs had twice the rate of infections, at 4 years of follow-up. Showing the benefits of avoiding invasive leads #SICDFirst #Extrathoracic #ESCCongress #BSCEMEA

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

With clinically proven performance, the S-ICD is an #extrathoracic device that has benefitted over 100,000 patients.
Learn more about the clinical data: https://t.co/MntzdTTVDe
#SICD #BSCEMEA

[Boston Scientific EMEA - Cardiology @BSC_EU_Heart]

Join our third instalment of New Horizons in AF, an educational conference which debuted in 2019.
Mark your calendar and experience ground-breaking approaches and therapies for the treatment of atrial fibrillation.
Learn more here: https://t.co/wPuABxtsVd
#BSCEMEA